Androgens and Hepatic Adenomas: A Review from a Urological Perspective

Emily Huang, Mukul Divatia, Manuel Villarreal, Brian J. Miles

Research output: Contribution to journalReview articlepeer-review


In the 21st century, there has been a significant increase in the use of testosterone replacement therapy (TRT) for men with symptoms of hypogonadism and a desire for more energy, muscle mass, etc. The TRT guidelines as defined by the American Urological Association have made all urologists familiar with the associated risks of polycythemia or infertility. However, there is a longer history and more persistent use of androgenic anabolic steroids (AAS) in men who are body building and trying to improve muscle mass. The goal of this mini review is to share and educate physicians on the additional risks of hepatic masses with the use of AAS and their pathophysiology.

Original languageEnglish (US)
Pages (from-to)166-173
Number of pages8
Issue number1
StatePublished - Dec 1 2022


  • androgen deprivation therapy
  • oncology

ASJC Scopus subject areas

  • Urology
  • Reproductive Medicine
  • Endocrinology


Dive into the research topics of 'Androgens and Hepatic Adenomas: A Review from a Urological Perspective'. Together they form a unique fingerprint.

Cite this